Annual Drug Patent Expiration for VITRAKVI
Vitrakvi is a drug marketed by Bayer Healthcare and Bayer Healthcare and is included in two NDAs. It is available from two suppliers. There are sixteen patents protecting this drug.
This drug has one hundred and seventy-seven patent family members in forty-nine countries.
The generic ingredient in VITRAKVI is larotrectinib sulfate. Two registered suppliers for this compound. Additional details are available on the larotrectinib sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for the drug Bayer Healthcare VITRAKVI